A study to see how two different agents, Mitomycin C (commonly used) and bevacizumab (newer agent)influence the outcome of surgery for medically uncontrolled glaucoma.
Phase 2
- Conditions
- Health Condition 1: null- Medically uncontrolled glaucoma
- Registration Number
- CTRI/2011/06/001836
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
- 18-70 years of age
-Patients with primary or secondary, open or closed angle glaucoma.
-Patients with intraocular pressure greater than 21 mmHg despite use of anti-glaucoma medications.
Exclusion Criteria
-Patients <18 years of age
-Pregnant and lactating females.
-Patients undergoing concurrent cataract surgery.
-Patients with failed trabeculectomy.
-Patients with active uveitis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method